JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Whole Liver Palliative Radiotherapy for Patients with Massive Liver Metastases
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Whole Liver Palliative Radiotherapy for Patients with Massive Liver Metastases
Edyta, Wolny-Rokicka; Jakub, Lipinski; Jerzy, Wydmanski;
  PDF(new window)
 Abstract
Background: The purpose of this retrospectively study was to examine the effectiveness and tolerability of a radiotherapy technique for the palliation of symptomatic liver metastases. Materials and Methods: Twentyseven patients with liver metastases were enrolled and received targeted whole liver irradiation consisting of mean 1, 8 Gy in five to twelve fractions to a total mean dose 17Gy. Symptoms at baseline were hepatic pain (26 patients), lost of weight (6), lack of appetite (2), and night sweats (1). Seventeen patients (63%) had failed previous treatment with chemotherapy and/or high-dose steroids. Results: Individual symptom response rates were 100% at 4 weeks. Partial or complete global symptomatic responses were noted in 11 patients (40%) after 2 months. After 3 months, 8 patients (28%) reported loss of pain. The treatment was well tolerated with one patient (3%) experiencing grade 3 toxicity (one vomiting and one diarrhoea). Overall the median survival time was 4.9 months (range 1 - 14 months). One year survival was 39%. Conclusions: This is simple and well-tolerated treatment but to achieve good palliation effects we should carefully selected patients whose conventional treatment does not bring good analgesic control.
 Keywords
Hepatic metastases;palliative radiotherapy;palliative treatment;
 Language
English
 Cited by
 References
1.
Bengtsson G, Carlsson G, Hafstrom L (1981). Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg, 141, 586-9 crossref(new window)

2.
Borgelt BB, Gelber R, Brady LW, Griffin T, et al (1981). The palliation of hepatic metastases: results of the radiationtherapy oncology group pilot study. Int J Radiat Oncol Biol Phys, 7, 587-91 crossref(new window)

3.
Cokmert S, Ellidokuz H, Demir L et al (2014). Survival outcomes of liver metastasectomy in colorectal cancer cases: a singlecenter analysis in Turkey. Asian Pac J Cancer Prev, 15, 5195-200 crossref(new window)

4.
Cunningham SC, Choti MA, Bellavance EC, Pawlik TM (2007). Palliation of hepatic tumors. Surg Oncol, 16, 277-291 crossref(new window)

5.
Chua TC, Liauw W, Koong HN, et al (2011). Surgical therapies in metastatic colorectal cancer with a potential for cure. Am J Clin Oncol, 34, 326-31 crossref(new window)

6.
Chung KY, Kemeny N, (2005). Regional and systemic chemiotherapy for primary hepatobiliary cancers and for colorectal cancer metastatic to the liver. Semin Radiat Oncol, 15, 284-298 crossref(new window)

7.
Eble MJ, Gademann G, Wannenmacher M (1993). The value of radiotherapy for liver metastases. Strahlenther Onkol, 169, 459-68

8.
Gallinger S, Biagi JJ, Fletcher GG, et al (2013). Liver resection for colorectal cancer metastases. Curr Oncol, 20, 255-65 crossref(new window)

9.
Hoyer M, Swaminath A, Bydder S, et al (2012). Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys, 82, 1047-57. crossref(new window)

10.
Krishan S, Lin EH, Gunn GB, Chandra A, et al (2006). Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Am J Clin Obcol, 29, 562-7 crossref(new window)

11.
Lochan R, White S, Manas DM (2007). Liver resection for colorectal liver metastasis. Surg Oncol, 16, 33-45

12.
Malik HZ, Gomez D, Wong V, Al-Mukthar A, (2007). Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. Eur J Surg Oncol, 33,1003-9 crossref(new window)

13.
Mendez Romero A, Hoyer M.(2012).Radiation therapy for liver metastases. Curr Opin Support Palliat Care, 6, 97-102 crossref(new window)

14.
Nordlinger B, Rougier P (2002). Liver metastases from colorectal cancer: the turning point. J Clin Oncol, 20, 1442-5

15.
Prasad B, Lee MS, Hendrickson FR (1977). Irradiation of hepatic metastases. Int J Radiat Oncol Biol Phys, 2, 129-32 crossref(new window)

16.
Russell AH, Clyde C, Wasserman TH, et al (1993). Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys, 27, 117-23.

17.
Sherman DM, Weichselbaum R, Order SE, Cloud L, et al (1978). Palliation of hepatic metastasis. Cancer, 41, 2013-7 crossref(new window)

18.
Suwinski R, Wydmanski J, Pawelczyk I et al (2006). A pilot study of accelerated preoperative hyperfractionated pelvic irradiation with or without low-dose preoperative prophylactic liver irradiation in patients with locally advanced rectal cancer. Radiother Oncol, 80, 27-32 crossref(new window)

19.
Tree AC, Khoo VS, Eeles RA, et al (2013). Stereotactic body radiotherapy for oligometastases. Lancet Oncol, 14, 28-37 crossref(new window)

20.
Turek-Maischeider M, Kazem I (1975). Palliative irradiation for liver metastases. JAMA, 232, 625-8 crossref(new window)

21.
Yin H, Lu K, Qiao WB et al (2014). Whole-liver radiotherapy concurrent with chemotherapy as a palliative treatment for colorectal patients with massive and multiple liver metastases: a retrospective study. Asian Pac J Cancer Prev, 15, 1597-602 crossref(new window)